Blood Plasma Derivatives Global Market Opportunities And Strategies To 2033
Description
Blood Plasma Derivatives Global Market Opportunities And Strategies To 2033
Including: 1) By Type: Albumin; Factor VIII; Factor IX; Immunoglobulin; Hyperimmune Globulin2) By Application: Haemophilia; Hypogammaglobulinemia; Immunodeficiency Diseases; Von Willebrand's Disease3) By End-User: Hospitals; ClinicsCovering: CSL Limited; China Biologic Products Holdings Inc.; Takeda Pharmaceutical Company Limited; Octapharma AG; Bayer AG
Blood Plasma Derivatives Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global blood plasma derivatives market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for blood plasma derivatives? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The blood plasma derivatives market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider blood plasma derivatives market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by application and by end-user.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the blood plasma derivatives market.
- Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
- Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations-This section includes recommendations for blood plasma derivatives providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
1) By Type: Albumin; Factor VIII; Factor IX; Immunoglobulin; Hyperimmune Globulin; Other Types
2) By Application: Haemophilia; Hypogammaglobulinemia; Immunodeficiency Diseases; Von Willebrand's Disease; Other Application
3) By End-User: Hospitals; Clinics; Other End-Users
Companies Mentioned: CSL Limited; China Biologic Products Holdings Inc.; Takeda Pharmaceutical Company Limited; Octapharma AG; Bayer AG
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; blood plasma derivatives indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
327 Pages
- 1 Executive Summary
- 1.1 Blood Plasma Derivatives – Market Attractiveness And Macro economic Landscape
- 2 Table Of Contents
- 3 List Of Tables
- 4 List Of Figures
- 5 Report Structure
- 6 Market Characteristics
- 6.1 General Market Definition
- 6.2 Summary
- 6.3 Blood Plasma Derivatives Market Definition And Segmentations
- 6.4 Market Segmentation By Type
- 6.4.1 Albumin
- 6.4.2 Factor VIII
- 6.4.3 Factor IX
- 6.4.4 Immunoglobulin
- 6.4.5 Hyperimmune Globulin
- 6.4.6 Other Types
- 6.5 Market Segmentation By Application
- 6.5.1 Hemophilia
- 6.5.2 Hypogammaglobulinemia
- 6.5.3 Immunodeficiency Diseases
- 6.5.4 Von Willebrand's Disease
- 6.5.5 Other Applications
- 6.6 Market Segmentation By End-User
- 6.6.1 Hospitals
- 6.6.2 Clinics
- 6.6.3 Other End-Users
- 7 Major Market Trends
- 7.1 New Blood Plasma Manufacturing Facilities To Enhance Supply Chain Resilience
- 7.2 Increasing Investments To Expand Blood Plasma Production Capabilities
- 7.3 Innovative Formulations To Address Hepatitis B Virus Exposure
- 7.4 Strategic Partnerships And Collaborations To Strengthen Blood Plasma Derivatives Development
- 8 Blood Plasma Derivatives Market - Macro Economic Scenario
- 8.1 COVID-19 Impact On The Blood Plasma Derivatives Market
- 8.2 Impact Of The War In Ukraine On The Blood Plasma Derivatives Market
- 8.3 Impact Of High Inflation On The Blood Plasma Derivatives Market
- 9 Global Market Size and Growth
- 9.1 Market Size
- 9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)
- 9.2.1 Market Drivers 2018 – 2023
- 9.2.2 Market Restraints 2018 – 2023
- 9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)
- 9.3.1 Market Drivers 2023 – 2028
- 9.3.2 Market Restraints 2023 – 2028
- 10 Global Blood Plasma Derivatives Market Segmentation
- 10.1 Global Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 10.2 Global Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 10.3 Global Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 11 Blood Plasma Derivatives Market, Regional and Country Analysis
- 11.1 Global Blood Plasma Derivatives Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 11.2 Global Blood Plasma Derivatives Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12 Asia-Pacific Market
- 12.1 Summary
- 12.1.1 Market Overview
- 12.1.2 Region Information
- 12.1.3 Market Information
- 12.1.4 Background Information
- 12.1.5 Government Initiatives
- 12.1.6 Regulations
- 12.1.7 Regulatory Bodies
- 12.1.8 Major Associations
- 12.1.9 Taxes Levied
- 12.1.10 Corporate Tax Structure
- 12.1.11 Investments
- 12.1.12 Major Companies
- 12.2 Asia-Pacific Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.3 Asia-Pacific Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.4 Asia-Pacific Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.5 Asia-Pacific Blood Plasma Derivatives Market: Country Analysis
- 12.6 China Market
- 12.7 Summary
- 12.7.1 Market Overview
- 12.7.2 Country Information
- 12.7.3 Market Information
- 12.7.4 Background Information
- 12.7.5 Government Initiatives
- 12.7.6 Regulations
- 12.7.7 Regulatory Bodies
- 12.7.8 Major Associations
- 12.7.9 Taxes Levied
- 12.7.10 Corporate Tax Structure
- 12.7.11 Investments
- 12.7.12 Major Companies
- 12.8 China Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.9 China Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.10 China Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.11 India Market
- 12.12 India Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.13 India Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.14 India Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.15 Japan Market
- 12.16 Japan Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.17 Japan Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.18 Japan Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.19 Australia Market
- 12.20 Australia Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.21 Australia Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.22 Australia Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.23 Indonesia Market
- 12.24 Indonesia Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.25 Indonesia Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.26 Indonesia Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.27 South Korea Market
- 12.28 South Korea Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.29 South Korea Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.30 South Korea Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13 Western Europe Market
- 13.1 Summary
- 13.1.1 Market Overview
- 13.1.2 Region Information
- 13.1.3 Market Information
- 13.1.4 Background Information
- 13.1.5 Government Initiatives
- 13.1.6 Regulations
- 13.1.7 Regulatory Bodies
- 13.1.8 Major Associations
- 13.1.9 Taxes Levied
- 13.1.10 Corporate Tax Structure
- 13.1.11 Investments
- 13.1.12 Major Companies
- 13.2 Western Europe Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.3 Western Europe Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.4 Western Europe Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.5 Western Europe Blood Plasma Derivatives Market: Country Analysis
- 13.6 UK Market
- 13.7 UK Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.8 UK Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.9 UK Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.10 Germany Market
- 13.11 Germany Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.12 Germany Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.13 Germany Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.14 France Market
- 13.15 France Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.16 France Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.17 France Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.18 Italy Market
- 13.19 Italy Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.20 Italy Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.21 Italy Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.22 Spain Market
- 13.23 Spain Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.24 Spain Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.25 Spain Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 14 Eastern Europe Market
- 14.1 Summary
- 14.1.1 Market Overview
- 14.1.2 Region Information
- 14.1.3 Market Information
- 14.1.4 Background Information
- 14.1.5 Government Initiatives
- 14.1.6 Regulations
- 14.1.7 Regulatory Bodies
- 14.1.8 Major Associations
- 14.1.9 Taxes Levied
- 14.1.10 Corporate Tax Structure
- 14.1.11 Investments
- 14.1.12 Major Companies
- 14.2 Eastern Europe Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 14.3 Eastern Europe Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 14.4 Eastern Europe Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 14.5 Eastern Europe Blood Plasma Derivatives Market: Country Analysis
- 14.6 Russia Market
- 14.7 Russia Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 14.8 Russia Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 14.9 Russia Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15 North America Market
- 15.1 Summary
- 15.1.1 Market Overview
- 15.1.2 Region Information
- 15.1.3 Market Information
- 15.1.4 Background Information
- 15.1.5 Government Initiatives
- 15.1.6 Regulations
- 15.1.7 Regulatory Bodies
- 15.1.8 Major Associations
- 15.1.9 Taxes Levied
- 15.1.10 Corporate Tax Structure
- 15.1.11 Investments
- 15.1.12 Major Companies
- 15.2 North America Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.3 North America Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.4 North America Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.5 North America Blood Plasma Derivatives Market: Country Analysis
- 15.6 USA Market
- 15.7 Summary
- 15.7.1 Market Overview
- 15.7.2 Country Information
- 15.7.3 Market Information
- 15.7.4 Background Information
- 15.7.5 Government Initiatives
- 15.7.6 Regulations
- 15.7.7 Regulatory Bodies
- 15.7.8 Major Associations
- 15.7.9 Taxes Levied
- 15.7.10 Corporate Tax Structure
- 15.7.11 Investments
- 15.7.12 Major Companies
- 15.8 USA Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.9 USA Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.10 USA Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.11 Canada Market
- 15.12 Canada Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.13 Canada Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.14 Canada Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 16 South America Market
- 16.1 Summary
- 16.1.1 Market Overview
- 16.1.2 Region Information
- 16.1.3 Market Information
- 16.1.4 Background Information
- 16.1.5 Government Initiatives
- 16.1.6 Regulations
- 16.1.7 Regulatory Bodies
- 16.1.8 Major Associations
- 16.1.9 Taxes Levied
- 16.1.10 Corporate Tax Structure
- 16.1.11 Major Companies
- 16.2 South America Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 16.3 South America Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 16.4 South America Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 16.5 South America Blood Plasma Derivatives Market: Country Analysis
- 16.6 Brazil Market
- 16.7 Brazil Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 16.8 Brazil Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 16.9 Brazil Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 17 Middle East Market
- 17.1 Summary
- 17.1.1 Market Overview
- 17.1.2 Region Information
- 17.1.3 Market Information
- 17.1.4 Background Information
- 17.1.5 Government Initiatives
- 17.1.6 Regulations
- 17.1.7 Regulatory Bodies
- 17.1.8 Major Associations
- 17.1.9 Taxes Levied
- 17.1.10 Corporate Tax Structure
- 17.1.11 Investments
- 17.1.12 Major Companies
- 17.2 Middle East Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 17.3 Middle East Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 17.4 Middle East Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 18 Africa Market
- 18.1 Summary
- 18.1.1 Market Overview
- 18.1.2 Region Information
- 18.1.3 Market Information
- 18.1.4 Background Information
- 18.1.5 Government Initiatives
- 18.1.6 Regulations
- 18.1.7 Regulatory Bodies
- 18.1.8 Major Associations
- 18.1.9 Taxes Levied
- 18.1.10 Corporate Tax Structure
- 18.1.11 Investments
- 18.1.12 Major Companies
- 18.2 Africa Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 18.3 Africa Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 18.4 Africa Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 19 Competitive Landscape And Company Profiles
- 19.1 Company Profiles
- 19.2 CSL Limited
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial Overview
- 19.3 China Biologic Products Holdings Inc.
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Financial Overview
- 19.4 Takeda Pharmaceutical Company Limited
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Performance
- 19.5 Octapharma AG
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Business Strategy
- 19.5.4 Financial Overview
- 19.6 Bayer AG
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Financial Performance
- 20 Blood Plasma Derivatives Market Other Major And Innovative Companies
- 20.1 Kedrion S.p.A.
- 20.1.1 Company Overview
- 20.1.2 Products And Services
- 20.2 Bio Products Ltd.
- 20.2.1 Company Overview
- 20.2.2 Products And Services
- 20.3 Grifols S.A.
- 20.3.1 Company Overview
- 20.3.2 Products And Services
- 20.4 LFB S.A.
- 20.4.1 Company Overview
- 20.4.2 Products And Services
- 20.5 ADMA Biologics Inc.
- 20.5.1 Company Overview
- 20.5.2 Products And Services
- 20.6 GC Biopharma Corp.
- 20.6.1 Company Overview
- 20.6.2 Products And Services
- 20.7 Shanghai Raas Blood Products Co. Ltd.
- 20.7.1 Company Overview
- 20.7.2 Products And Services
- 20.8 Emergent BioSolutions Inc.
- 20.8.1 Company Overview
- 20.8.2 Products And Services
- 20.9 Biotest AG
- 20.9.1 Company Overview
- 20.9.2 Products And Services
- 20.10 SK Plasma Co., Ltd.
- 20.10.1 Company Overview
- 20.10.2 Products And Services
- 20.11 BioreclamationIVT
- 20.11.1 Company Overview
- 20.11.2 Products And Services
- 20.12 Fusion Health Care Pvt. Ltd.
- 20.12.1 Company Overview
- 20.12.2 Products And Services
- 20.13 PlasmaGen BioSciences Private Limited
- 20.13.1 Company Overview
- 20.13.2 Products And Services
- 20.14 Cambryn Biologics LLC
- 20.14.1 Company Overview
- 20.14.2 Products And Services
- 20.15 Sanquin Innovation B.V.
- 20.15.1 Company Overview
- 20.15.2 Products And Services
- 21 Competitive Benchmarking
- 22 Competitive Dashboard
- 23 Key Mergers And Acquisitions
- 23.1 Pfizer Inc. Acquired Blood Therapeutics Inc.
- 23.2 Grifols S.A. Acquired Biotest AG
- 23.3 Grifols S.A. Acquired 25 Plasma Centers From BPL Plasma Inc.
- 23.4 Permira Acquired Kedrion Biopharma
- 23.5 Kamada Ltd. Acquired FDA-Licensed Plasma Collection Center From Blood and Plasma Research Inc.
- 24 Opportunities And Strategies
- 24.1 Global Blood Plasma Derivatives Market In 2028 – Countries Offering Most New Opportunities
- 24.2 Global Blood Plasma Derivatives Market In 2028 – Segments Offering Most New Opportunities
- 24.3 Global Blood Plasma Derivatives Market In 2028 – Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies
- 25 Blood Plasma Derivatives Market, Conclusions And Recommendations
- 25.1 Conclusions
- 25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People
- 26 Appendix
- 26.1 Geographies Covered
- 26.2 Market Data Sources
- 26.3 Research Methodology
- 26.4 Currencies
- 26.5 The Business Research Company
- 26.6 Copyright and Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
